BreakSight’s vision is to advance precision medicine by uncovering precise maps of DNA damage. Our technology identifies site-specific DNA breakage across the genome from DNA-damaging compounds. Our innovative and comprehensive platform enables discovery of novel DNA biomarkers of drug response by unraveling mechanisms of genomic instability caused by targeted therapeutics.

Inotiv provides a fully integrated drug discovery solution customized to your company’s project goals. We provide pharmacological, toxicological, and in vitro/in vivo assessment across multiple therapeutic areas and species to ensure the right studies are performed at the right time.